Navigation Links
Vikingselect™ Intra-Operative Monitoring (IOM)

ProductsVikingselect™ Intra-Operative Monitoring (IOM)
Company VIASYS Healthcare (Nicolet Biomedical)
Item Vikingselect™ Intra-Operative Monitoring (IOM)
Features Minimize risks during surgical procedures involving the brain and nervous system. Time-stamped event notation, data trending of latencies and amplitudes. Quick visual overview of the case using curve stacks and trendplots on-line. Special software allows simultaneous frequency analysis of EEG with acquisition of EMG, EP, and nerve data. Optional networking for remote on-line review during the surgery. Linked parameters for faster changes during acquisition.
Description Vikingselect™ Intra-Operative Monitoring (IOM).
Info VIASYS Healthcare (Nicolet Biomedical)
Customer Service: (800) 356-0007
Web site: http://www.nicoletbiomedical.com/

Related medicine products :

1. Intra-Operative MRI
2. Vikingselect Intra-Operative Monitoring (IOM)
3. ICP Express Monitoring System
4. Ventrix™ NL950-100 Intercranial Pressure Monitoring System
5. Spiegelberg ICP Monitoring - ICP-Monitor
6. Monitorr ICP External CSF Drainage and Monitoring System
7. Becker External Drainage and Monitoring System
8. LICOX Brain Tissue Oxygen Monitoring System
9. Teca Synergy T-EP - EMG/EP Monitoring Systems
10. Beehive Millennium - Long-term Epilepsy Monitoring
11. LifeWatch® Ambulatory ECG Monitoring
These specialty razor blades are feather thin and very sharp. Most users have found an increased quality level in Vibratome sections with these blades.
This is a perfect tool for retrieving free floating sections from the Vibratome bath.
The care package includes a spare motor, fuse, Spare Fluorescent Bulb, additional Vibratome Feather Blades, Specimen Adhesive, Specimen Mounting Blocks, and a Specimen Tray.
Vibratome Specimen Adhesive is a special formulation developed by a major adhesive manufacturer for applications such as tissue mounting. The advantage of this adhesive is that it has a strong holdi
Medicine Products:
(Date:11/21/2008)... Barr Pharmaceuticals, In...lders overwhelmingly approved the proposals submit... Teva Pharmaceuticals Industries Ltd. (Nasdaq: T...overwhelming support of the transaction by the Bar...rman and CEO. "We are pleased with the progress th...
(Date:11/21/2008)... deadly diseaseits cause remains a mysteryswept in... with citizens, soldiers and refugees of the war t...illed with corpses, social order broke down. Over ...nd Athens lost a third of its population. It lost ...ning of the end of the Golden Age of Greece. , ...
(Date:11/21/2008)... 21 A prestigious group of physici...gather in Williamsburg, VA on March 27-29, 2009 at...al information on cutting-edge therapeutic protoco...search advances that impact patient care. The full... information is available at www.bioconferences.c...
(Date:11/21/2008)...use is more prevalent and smoking cessation less l...tivity Disorder (A.D.H.D.) In a study of smokers ... those who exhibited elevated hyperactivity and im...er quit rates after 8 weeks than those with inatte... symptoms. The study, now available online in Ni...
Breaking Medicine News(10 mins):Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4Health News:17th Annual Congress on Women's Health Convenes March 27-29, 2009 in Williamsburg, VA 2Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2
...leadership in the companion fields of stem cell re...of Wisconsin-Madison will establish a new Stem Cel...ent of the new center, to be made today (May 17) a...ental biologist Ian Wilmut, the creator of the clo...
...uffer in silence, cough up more money to get thing...lts. And here comes the news that a hospital grou...its workmanship, charging a flat fee that includes...nt. Even if a patient suffers complications or ha...
...are, Dr. David Parirenyatwa, says that the illegal...verely compromised the country's health delivery ... World Health Assembly in Geneva, Switzerland, to ...onditional lifting of these sanctions. He calls t...
... response to numerous complaints over local health...tient clinic in Evansville city that would open b...ut 87,000 square feet that must be available for o...l veterans have complained for nearly two years ab...
Other Medicine News:Health News:UW Establishes Stem Cell and Regenerative Medicine Center 2Health News:US Hospital Group Offers Warranty on Surgeries 2Health News:US Hospital Group Offers Warranty on Surgeries 3Health News:Sanctions Imposed On Zimbabwe Can Threaten International Health Security 2
(Date:11/19/2008)...ewswire-FirstCall/ -- Amgen,(Nasdaq: AMGN ) and...iary of,Takeda Pharmaceutical Company Limited (TS...Phase 3 MONET1 trial evaluating motesanib (AMG 706...for the first-line treatment of,advanced non-smal...spended,following a planned safety data review of...
(Date:11/19/2008)...oche- , , MONTVALE, N.J., Nov. 19 /PRNewswi...daq: MEMY ) today announced that it has achieved...7/MEM 3454, its lead alpha-7 nicotinic receptor ag...izophrenia (CIAS). The Company has randomized 212...million payment from its partner Roche. Memory Ph...
(Date:11/18/2008)...ces of Influenza survey underscores that mothers n...other and Gold Medalist Kristi Yamaguchi joins ini...e/ -- While 78 percent of mothers in the United St...ife-threatening disease that can strike anyone, on...accinated this season, according to a new survey f...
(Date:11/12/2008)...SNewswire/ -- A new study being,published in this ...he,question, what causes Parkinson,s disease?, On...search into,Parkinson,s disease is what causes the...place. Answering this question has been especially...types of brain cells that produce,dopamine and the...
Breaking Medicine Technology:Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6A Window Into Parkinson's Disease 2Novadaq to hold first quarter 2008 results conference call and webcast 18133 1Novadaq to hold first quarter 2008 results conference call and webcast 18133 2Novadaq to hold first quarter 2008 results conference call and webcast 18133 3Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey 28TM 29 Network 5015 1Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey 28TM 29 Network 5015 2Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey 28TM 29 Network 5015 3Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey 28TM 29 Network 5015 4Haunted by hallucinations 3A Children in the PICU traumatized by delusions 18131 1Haunted by hallucinations 3A Children in the PICU traumatized by delusions 18131 2Study raises questions about prostate cancer therapies targeting IGF 1 18128 1Study raises questions about prostate cancer therapies targeting IGF 1 18128 2
...CAGO--(BUSINESS WIRE)--Jun 4, 2007 - Genentech, In... a joint analysis of two Phase,III clinical trials...ant treatment of HER2-positive breast cancer. Data...can Society of Clinical,Oncology (ASCO) showed tha...e addition of Herceptin to standard adjuvant thera...
...UTH SAN FRANCISCO, Calif., June 04, 2007,/PRNewswi...d,follow-up data from a Phase 2 clinical trial of ... conducted by the Johns Hopkins,Sidney Kimmel Canc...rable pancreatic cancer who received GVAX after su...tion and,chemotherapy. , ,The median overall survi...
Other Medicine Technology:Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 2Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 3Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 4Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 5Updated Overall Survival Data From Pivotal Herceptin Adjuvant,Studies in HER2-Positive Breast Cancer 6Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 2Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 3Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 4Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of,GVAX Immunotherapy for Pancreatic Cancer 5